BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Orexin/Hypocretin receptor type 1' and Ligand = 'BDBM347775'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Orexin/Hypocretin receptor type 1


(Homo sapiens (Human))
BDBM347775
PNG
(US9790220, Example 8)
Show SMILES CC(C)Oc1cccnc1C(=O)N[C@H]1CCC[C@@H]1Nc1nc2ccc(F)cc2s1 |r|
Show InChI InChI=1S/C21H23FN4O2S/c1-12(2)28-17-7-4-10-23-19(17)20(27)24-14-5-3-6-15(14)25-21-26-16-9-8-13(22)11-18(16)29-21/h4,7-12,14-15H,3,5-6H2,1-2H3,(H,24,27)(H,25,26)/t14-,15-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 34n/an/an/an/an/an/a



Takeda Pharmaceutical Company Limited

US Patent


Assay Description
Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...


US Patent US9790220 (2017)


BindingDB Entry DOI: 10.7270/Q2FF3VHB
More data for this
Ligand-Target Pair